← FDA Drug Approvals (Drugs@FDA)

ABACAVIR SULFATE; LAMIVUDINE

NDA · New Drug Application · Sponsor: CIPLA LIMITED · Approved 2011-05-12

Drug application

FDA Application #

NDA202007

Application type

New Drug Application

Brand name

ABACAVIR SULFATE; LAMIVUDINE

Generic name

Abacavir Sulfate

Active ingredients

ABACAVIR SULFATE; LAMIVUDINE

Dosage form

TABLET, FOR SUSPENSION

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

CIPLA LIMITED

First approval

2011-05-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown